Find your next paid study

M.D. Anderson Cancer CenterNCT04140487

~$150 – $3,000

Actual pay is set by the research site.

Fetoscopic Neural Tube Defect Repair: Observational Pilot Study

This is a single-arm prospective study to record maternal and neonatal outcomes on subjects who undergo fetoscopic repair of Neural Tube Defects (NTD) at Orego…

Neural Tube DefectsSpina Bifida

Oregon Health and Science UniversityNCT06946563

Actual pay is set by the research site.

Implant Based Breast Reconstruction

Safety And Effectiveness Of FlexHD® Pliable Acellular Dermal Matrix In Implant-Based Breast Reconstruction

Prospective, multi-center, single-arm clinical study in females undergoing immediate implant-based breast reconstruction using a pre-pectoral technique

Musculoskeletal Transplant FoundationNCT06797258

Actual pay is set by the research site.

Use of an Educational Video to Improve Caregiver Knowledge, Adherence to Recommendations, and Outcomes in Children With Dysfunctional Voiding

This study aims to see whether an educational video on a common urinary dysfunction leads to improved parent and child perceived adherence to treatments recomm…

Dysfunctional Voiding

University of Colorado, DenverNCT06909552

Actual pay is set by the research site.

Sexually Transmitted Infections (Not HIV or Hepatitis)HIV InfectionsSexual Behavior

A Family-Based HIV Prevention Program for Black Men to Protect Black Girls

The scientific premise of this research is that individual, interpersonal, and structural factors impact Black girls' sexual reproductive health outcomes (sexu…

University of Illinois at ChicagoNCT06266416

Actual pay is set by the research site.

Phase 2

Cardiac and Metabolic Effects of Dapagliflozin in the Failing Fontan Circulation: A Phase II, Prospective, Double-Blind Study

The purpose of this research is to determine whether treatment with the study drug dapagliflozin for 3 months affects peripheral venous pressure at rest and du…

Fontan CirculationSingle Ventricle Heart DiseaseHFpEF - Heart Failure With Preserved Ejection Fraction

~$75 – $2,000

Actual pay is set by the research site.

Mayo ClinicNCT06762964

Mitral Regurgitation Functional

ENHANCE EFS: Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System

Safety and performance evaluation of the CARLEN System in patients with functional mitral valve regurgitation.

Nyra Medical, Inc.NCT07503236

~$10 – $1,050

Actual pay is set by the research site.

Phase 1

Modified FOLFIRINOX and Pentamidine as First-line Treatment in Advanced and Metastatic Pancreatic Ductal Adenocarcinoma

The purpose of this research is to observe the effects of using a new combination of drugs to inhibit tumor growth.

Pancreatic Ductal Adenocarcinoma (PDAC)

University of OklahomaNCT07829185

~$150 – $3,000

Actual pay is set by the research site.

Phase 4

Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use

The objective of this study is to evaluate whether reduction in topical medication with the injection of a sustained release capsule (Durysta) leads to a reduc…

GlaucomaOpen-Angle GlaucomaOcular Hypertension+1 more

University of MiamiNCT07217678

~$25 – $1,000

Actual pay is set by the research site.

DepressionECTCognitive Change

Amplitude Titration to Improve ECT Clinical Outcomes Randomized Clinical Trial

A randomized controlled trial will compare hippocampal neuroplasticity, antidepressant, and cognitive outcomes between individualized amplitude and fixed 800 m…

University of New MexicoNCT05699226

Actual pay is set by the research site.

Immuno-Virological Evaluation of Human T Cell Leukemia Virus Type-1 Associated Myelopathy (HAM/TSP)

Objective: Human T-lymphotropic virus type-I-associated myelopathy / tropical spastic paraparesis (HAM/TSP) is a rare neurologic disorder that affects less th…

HTLV-I InfectionTropical Spastic Paraparesis

National Institute of Neurological Disorders and Stroke (NINDS)NCT00001778

~$10 – $675

Actual pay is set by the research site.

Phase 1

A Phase I/II Study of ASTX727, Venetoclax, and Gilteritinib for Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome With an Activating FLT3 Mutation

This phase I/II trial studies the best dose of gilteritinib given together with ASTX727 and venetoclax and the effect of ASTX727, venetoclax, and gilteritinib …

Acute Myeloid LeukemiaMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia+1 more